FinTrust Capital Advisors’s Helus Pharma Inc. Common Stock HELP Stock Holding History

FinTrust Capital Advisors’s Portfolio HELP Stock Details HELP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13	Closed	-$265	–	1277
2023 Q3	$265	Hold	13	–	–	﹤0.01%	1188
2023 Q2	$154	Hold	13	–	–	﹤0.01%	1173
2023 Q1	$154	Hold	13	–	–	﹤0.01%	1162
2022 Q4	$153	Hold	13	–	–	﹤0.01%	1160
2022 Q3	$0	Buy	+13	New	+$352	﹤0.01%	1230

Other funds holding HELP

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

PDS Planning Dublin, Ohio $1.73B AUM 24.11% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

LAM

Lewis Asset Management Lafayette, California $285M AUM 32.52% 1-Year Est. Return

FinTrust Capital Advisors's HELP Position: Q4 2023 in Review

FinTrust Capital Advisors sold out of Helus Pharma Inc. Common Stock (HELP) in Q4 2023, closing a stake of 13 shares — an estimated $265 sold.

FinTrust Capital Advisors first reported a position in HELP in Q3 2022 and held it in 5 quarters. The position peaked at $265 in Q3 2023. 86 funds tracked by Wall St. Rank hold HELP as of Q4 2023.

FinTrust Capital Advisors reported no remaining Helus Pharma Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
FinTrust Capital Advisors sold 13 Helus Pharma Inc. Common Stock shares in Q4 2023, an estimated $265.
FinTrust Capital Advisors first reported a position in Helus Pharma Inc. Common Stock in Q3 2022 and held it in 5 quarters.
FinTrust Capital Advisors's Helus Pharma Inc. Common Stock position peaked at $265 in Q3 2023.
86 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q4 2023.

Based on FinTrust Capital Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.